MarketCap
Facebook
X
TelegramFluidigm Corporation DSO Ratio 2011-2026 | FLDM
Annual DSO Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 67.2 | 59.1 | 53.8 | 53.9 | 51.1 | 81 | 70.2 | 54.1 | 90 | 78.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90 | 51.1 | 65.9 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Biomerica
BMRA
|
57.7 | $ 2.16 | 1.41 % | $ 4.96 M |  USA |
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
82.1 | $ 9.15 | 1.67 % | $ 610 M | USA |
|
Biodesix
BDSX
|
41.7 | $ 15.54 | 5.79 % | $ 2.02 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.34 | 0.06 % | $ 494 M | USA |
 |
Guardant Health
GH
|
46.1 | $ 83.59 | -1.54 % | $ 10.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 101.28 | 0.93 % | $ 8.35 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
43.5 | $ 570.21 | -1.43 % | $ 45.9 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 74.24 | -1.97 % | $ 5.01 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 460.74 | 0.83 % | $ 13.3 B | USA |
 |
Myriad Genetics
MYGN
|
52.3 | $ 4.61 | -1.07 % | $ 427 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 17.44 | -0.4 % | $ 390 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Pacific Biosciences of California
PACB
|
71.8 | $ 1.39 | - | $ 417 M | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Personalis
PSNL
|
55.8 | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
Co-Diagnostics
CODX
|
101 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
RadNet
RDNT
|
34.5 | $ 59.87 | -3.03 % | $ 4.5 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
10.3 | $ 6.66 | 0.6 % | $ 278 M | USA |
 |
Sotera Health Company
SHC
|
43.9 | $ 13.84 | -0.32 % | $ 3.93 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
27 | $ 31.34 | -1.2 % | $ 1.59 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 159.19 | 0.75 % | $ 7.89 B | USA |
 |
IQVIA Holdings
IQV
|
73.9 | $ 166.09 | -0.52 % | $ 28.6 B | USA |
 |
Neuronetics
STIM
|
48.7 | $ 1.46 | -9.06 % | $ 96.3 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
63.7 | $ 1.18 | -19.18 % | $ 6.43 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 264.46 | 2.05 % | $ 26.1 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
53.1 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 125.98 | 1.77 % | $ 20 B | USA |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 47.49 | 6.72 % | $ 2.84 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
28.1 | $ 26.6 | -1.23 % | $ 34.5 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 266.12 | 0.64 % | $ 22.1 B | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 3.46 | -0.57 % | $ 1.86 M | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 7.86 | -2.96 % | $ 1.01 B | USA |
 |
Natera
NTRA
|
81.5 | $ 194.52 | -2.78 % | $ 19.1 B | USA |